EUROFINS SCIENTIFIC (ERF.PA) Fundamental Analysis & Valuation

EPA:ERF • FR0014000MR3

Current stock price

62.22 EUR
+0.94 (+1.53%)
Last:

This ERF.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. ERF.PA Profitability Analysis

1.1 Basic Checks

  • In the past year ERF was profitable.
  • In the past year ERF had a positive cash flow from operations.
  • Each year in the past 5 years ERF has been profitable.
  • Each year in the past 5 years ERF had a positive operating cash flow.
ERF.PA Yearly Net Income VS EBIT VS OCF VS FCFERF.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

1.2 Ratios

  • ERF has a Return On Assets (3.73%) which is comparable to the rest of the industry.
  • ERF has a Return On Equity of 9.02%. This is in the better half of the industry: ERF outperforms 63.16% of its industry peers.
  • ERF has a Return On Invested Capital of 9.81%. This is in the better half of the industry: ERF outperforms 73.68% of its industry peers.
  • ERF had an Average Return On Invested Capital over the past 3 years of 8.67%. This is in line with the industry average of 9.20%.
  • The 3 year average ROIC (8.67%) for ERF is below the current ROIC(9.81%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.73%
ROE 9.02%
ROIC 9.81%
ROA(3y)3.11%
ROA(5y)4.62%
ROE(3y)6.89%
ROE(5y)9.79%
ROIC(3y)8.67%
ROIC(5y)10.11%
ERF.PA Yearly ROA, ROE, ROICERF.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • ERF's Profit Margin of 6.06% is on the low side compared to the rest of the industry. ERF is outperformed by 63.16% of its industry peers.
  • In the last couple of years the Profit Margin of ERF has declined.
  • ERF has a Operating Margin of 16.10%. This is comparable to the rest of the industry: ERF outperforms 47.37% of its industry peers.
  • ERF's Operating Margin has declined in the last couple of years.
  • ERF has a Gross Margin of 24.29%. This is amonst the worse of the industry: ERF underperforms 84.21% of its industry peers.
  • ERF's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 16.1%
PM (TTM) 6.06%
GM 24.29%
OM growth 3Y1.4%
OM growth 5Y-3.07%
PM growth 3Y-11.18%
PM growth 5Y-8.18%
GM growth 3Y2.52%
GM growth 5Y-1.34%
ERF.PA Yearly Profit, Operating, Gross MarginsERF.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20 25

5

2. ERF.PA Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ERF is still creating some value.
  • Compared to 1 year ago, ERF has less shares outstanding
  • ERF has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for ERF is higher compared to a year ago.
ERF.PA Yearly Shares OutstandingERF.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
ERF.PA Yearly Total Debt VS Total AssetsERF.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

2.2 Solvency

  • ERF has an Altman-Z score of 2.54. This is not the best score and indicates that ERF is in the grey zone with still only limited risk for bankruptcy at the moment.
  • The Altman-Z score of ERF (2.54) is comparable to the rest of the industry.
  • ERF has a debt to FCF ratio of 5.14. This is a neutral value as ERF would need 5.14 years to pay back of all of its debts.
  • ERF has a Debt to FCF ratio of 5.14. This is in the better half of the industry: ERF outperforms 68.42% of its industry peers.
  • A Debt/Equity ratio of 0.82 indicates that ERF is somewhat dependend on debt financing.
  • The Debt to Equity ratio of ERF (0.82) is worse than 63.16% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.82
Debt/FCF 5.14
Altman-Z 2.54
ROIC/WACC1.18
WACC8.3%
ERF.PA Yearly LT Debt VS Equity VS FCFERF.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

2.3 Liquidity

  • ERF has a Current Ratio of 1.09. This is a normal value and indicates that ERF is financially healthy and should not expect problems in meeting its short term obligations.
  • ERF has a Current ratio (1.09) which is comparable to the rest of the industry.
  • ERF has a Quick Ratio of 1.03. This is a normal value and indicates that ERF is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Quick ratio value of 1.03, ERF perfoms like the industry average, outperforming 52.63% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.09
Quick Ratio 1.03
ERF.PA Yearly Current Assets VS Current LiabilitesERF.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

4

3. ERF.PA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 12.73% over the past year.
  • The Earnings Per Share has been decreasing by -3.15% on average over the past years.
  • Looking at the last year, ERF shows a decrease in Revenue. The Revenue has decreased by -2.80% in the last year.
  • ERF shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.43% yearly.
EPS 1Y (TTM)12.73%
EPS 3Y-9.04%
EPS 5Y-3.15%
EPS Q2Q%6.78%
Revenue 1Y (TTM)-2.8%
Revenue growth 3Y0.22%
Revenue growth 5Y4.43%
Sales Q2Q%4.3%

3.2 Future

  • ERF is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.11% yearly.
  • Based on estimates for the next years, ERF will show a small growth in Revenue. The Revenue will grow by 7.47% on average per year.
EPS Next Y8.32%
EPS Next 2Y11.81%
EPS Next 3Y13.96%
EPS Next 5Y16.11%
Revenue Next Year4.69%
Revenue Next 2Y5.62%
Revenue Next 3Y5.95%
Revenue Next 5Y7.47%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ERF.PA Yearly Revenue VS EstimatesERF.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2B 4B 6B 8B
ERF.PA Yearly EPS VS EstimatesERF.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6

5

4. ERF.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 16.73, the valuation of ERF can be described as correct.
  • ERF's Price/Earnings ratio is a bit cheaper when compared to the industry. ERF is cheaper than 73.68% of the companies in the same industry.
  • ERF is valuated rather cheaply when we compare the Price/Earnings ratio to 26.11, which is the current average of the S&P500 Index.
  • With a Price/Forward Earnings ratio of 15.95, ERF is valued correctly.
  • Based on the Price/Forward Earnings ratio, ERF is valued a bit cheaper than the industry average as 73.68% of the companies are valued more expensively.
  • The average S&P500 Price/Forward Earnings ratio is at 24.12. ERF is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 16.73
Fwd PE 15.95
ERF.PA Price Earnings VS Forward Price EarningsERF.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ERF is valued cheaper than 84.21% of the companies in the same industry.
  • 94.74% of the companies in the same industry are more expensive than ERF, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 13.14
EV/EBITDA 8.27
ERF.PA Per share dataERF.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • ERF's earnings are expected to grow with 13.96% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.01
PEG (5Y)N/A
EPS Next 2Y11.81%
EPS Next 3Y13.96%

6

5. ERF.PA Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 1.17%, ERF has a reasonable but not impressive dividend return.
  • ERF's Dividend Yield is rather good when compared to the industry average which is at 0.54. ERF pays more dividend than 84.21% of the companies in the same industry.
  • Compared to the average S&P500 Dividend Yield of 1.91, ERF is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.17%

5.2 History

  • On average, the dividend of ERF grows each year by 16.09%, which is quite nice.
Dividend Growth(5Y)16.09%
Div Incr Years1
Div Non Decr Years1
ERF.PA Yearly Dividends per shareERF.PA Yearly Dividends per shareYearly Dividends per share 2018 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

  • 26.80% of the earnings are spent on dividend by ERF. This is a low number and sustainable payout ratio.
  • ERF's earnings are growing around the same pace than its dividend. As long as the earnings growth is kept the dividend growth is sustainable.
DP26.8%
EPS Next 2Y11.81%
EPS Next 3Y13.96%
ERF.PA Yearly Income VS Free CF VS DividendERF.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
ERF.PA Dividend Payout.ERF.PA Dividend Payout, showing the Payout Ratio.ERF.PA Dividend Payout.PayoutRetained Earnings

ERF.PA Fundamentals: All Metrics, Ratios and Statistics

EUROFINS SCIENTIFIC

EPA:ERF (3/17/2026, 7:00:00 PM)

62.22

+0.94 (+1.53%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)01-29
Earnings (Next)04-22
Inst Owners33.9%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap11.33B
Revenue(TTM)6.76B
Net Income(TTM)409.70M
Analysts72
Price Target72.41 (16.38%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.17%
Yearly Dividend0.6
Dividend Growth(5Y)16.09%
DP26.8%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.43%
PT rev (3m)10.16%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-3.42%
EPS NY rev (3m)-1.72%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.98%
Revenue NY rev (3m)-0.9%
Valuation
Industry RankSector Rank
PE 16.73
Fwd PE 15.95
P/S 1.68
P/FCF 13.14
P/OCF 8.1
P/B 2.49
P/tB N/A
EV/EBITDA 8.27
EPS(TTM)3.72
EY5.98%
EPS(NY)3.9
Fwd EY6.27%
FCF(TTM)4.73
FCFY7.61%
OCF(TTM)7.68
OCFY12.34%
SpS37.09
BVpS24.94
TBVpS-4.41
PEG (NY)2.01
PEG (5Y)N/A
Graham Number45.69
Profitability
Industry RankSector Rank
ROA 3.73%
ROE 9.02%
ROCE 12.72%
ROIC 9.81%
ROICexc 10.81%
ROICexgc 34.71%
OM 16.1%
PM (TTM) 6.06%
GM 24.29%
FCFM 12.76%
ROA(3y)3.11%
ROA(5y)4.62%
ROE(3y)6.89%
ROE(5y)9.79%
ROIC(3y)8.67%
ROIC(5y)10.11%
ROICexc(3y)9.6%
ROICexc(5y)11.01%
ROICexgc(3y)30.56%
ROICexgc(5y)36.02%
ROCE(3y)11.39%
ROCE(5y)13.27%
ROICexgc growth 3Y-1.05%
ROICexgc growth 5Y-8.2%
ROICexc growth 3Y1.16%
ROICexc growth 5Y-4.51%
OM growth 3Y1.4%
OM growth 5Y-3.07%
PM growth 3Y-11.18%
PM growth 5Y-8.18%
GM growth 3Y2.52%
GM growth 5Y-1.34%
F-Score6
Asset Turnover0.62
Health
Industry RankSector Rank
Debt/Equity 0.82
Debt/FCF 5.14
Debt/EBITDA 2.05
Cap/Depr 74.23%
Cap/Sales 7.94%
Interest Coverage 9.42
Cash Conversion 77.25%
Profit Quality 210.5%
Current Ratio 1.09
Quick Ratio 1.03
Altman-Z 2.54
F-Score6
WACC8.3%
ROIC/WACC1.18
Cap/Depr(3y)77.81%
Cap/Depr(5y)87.04%
Cap/Sales(3y)8%
Cap/Sales(5y)8.27%
Profit Quality(3y)205.64%
Profit Quality(5y)166.63%
High Growth Momentum
Growth
EPS 1Y (TTM)12.73%
EPS 3Y-9.04%
EPS 5Y-3.15%
EPS Q2Q%6.78%
EPS Next Y8.32%
EPS Next 2Y11.81%
EPS Next 3Y13.96%
EPS Next 5Y16.11%
Revenue 1Y (TTM)-2.8%
Revenue growth 3Y0.22%
Revenue growth 5Y4.43%
Sales Q2Q%4.3%
Revenue Next Year4.69%
Revenue Next 2Y5.62%
Revenue Next 3Y5.95%
Revenue Next 5Y7.47%
EBIT growth 1Y4.52%
EBIT growth 3Y1.62%
EBIT growth 5Y1.23%
EBIT Next Year81.37%
EBIT Next 3Y28.68%
EBIT Next 5Y24.78%
FCF growth 1Y9.1%
FCF growth 3Y21.91%
FCF growth 5Y-0.13%
OCF growth 1Y6.07%
OCF growth 3Y7.18%
OCF growth 5Y2.72%

EUROFINS SCIENTIFIC / ERF.PA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of EUROFINS SCIENTIFIC (ERF.PA) stock?

ChartMill assigns a fundamental rating of 5 / 10 to ERF.PA.


What is the valuation status for ERF stock?

ChartMill assigns a valuation rating of 5 / 10 to EUROFINS SCIENTIFIC (ERF.PA). This can be considered as Fairly Valued.


Can you provide the profitability details for EUROFINS SCIENTIFIC?

EUROFINS SCIENTIFIC (ERF.PA) has a profitability rating of 5 / 10.


What is the earnings growth outlook for EUROFINS SCIENTIFIC?

The Earnings per Share (EPS) of EUROFINS SCIENTIFIC (ERF.PA) is expected to grow by 8.32% in the next year.


Can you provide the dividend sustainability for ERF stock?

The dividend rating of EUROFINS SCIENTIFIC (ERF.PA) is 6 / 10 and the dividend payout ratio is 26.8%.